CE
Celanese Corp
NYSE · Basic Materials · Chemicals · US
$47.88
+0.82%Year over year
Reported trailing growth
- Revenue
- -2.3%
- EBITDA
- +49.2%
- EBIT
- +9.8%
- EPS
- +27.9%
- Free cash flow
- +12.0%
- Operating cash flow
- -3.5%
Forward estimates
Based on analyst estimates
- Revenue
- +2.8%
- EBITDA
- +559.5%
- EPS
- +157.0%
Three-year CAGR
- Revenue
- -0.4%
- EBITDA
- -47.4%
- EBIT
- -17.7%
- Net income
- +23.5%
- EPS
- +23.6%
- Free cash flow
- -14.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026